No increased systemic fibrinolysis in women with heavy menstrual bleeding.

Wiewel-Verschueren, S; Knol, H M; Lisman, T; Bogchelman, D H; Kluin-Nelemans, J C; van der Zee, A G J; Mulder, A B; Meijer, K

Wiewel-Verschueren, S; Knol, H M; Lisman, T; Bogchelman, D H; Kluin-Nelemans, J C; van der Zee, A G J; Mulder, A B; Meijer, K.

Affiliation

Wiewel-Verschueren S; Division of Hemostasis and Thrombosis, Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

J Thromb Haemost ; 12(9): 1488-93, 2014 Sep.

Article in En | MEDLINE | ID: mdl-24954113

Subject(s)

Carboxypeptidase B2/metabolism; Endometrium/metabolism; Fibrinolysis; Menorrhagia/complications; Plasminogen Activator Inhibitor 1/metabolism; Adult; Blood Coagulation; Blood Coagulation Tests; Body Mass Index; Case-Control Studies; Endometrium/pathology; Female; Healthy Volunteers; Hemorrhage/complications; Hemostasis; Humans; Menstruation; Middle Aged

Key words

clot lysis time; fibrin; fibrinolysis; menorrhagia; plasminogen activator inhibitor 1; thrombin-activatable fibrinolysis inhibitor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasminogen Activator Inhibitor 1 / Carboxypeptidase B2 / Endometrium / Fibrinolysis / Menorrhagia Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2014 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google